Moneycontrol PRO
LAMF
LAMF

Dr. Reddy's Allots 4,160 Equity Shares Under ESOP Scheme

Dr. Reddy's Allots 4,160 Equity Shares Under ESOP Scheme
August 20, 2025 / 12:07 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

Dr. Reddy's Laboratories (DRREDDY) announced the allotment of 4,160 equity shares on August 20, 2025, pursuant to the exercise of stock options under its Employees Stock Options Scheme, 2002.

The pharmaceutical company allotted 4,160 equity shares with a face value of Re. 1 each, fully paid up, to eligible employees.

The shares were issued and allotted on August 20, 2025. The exercise price per share is Re. 1.

The distinctive numbers of the shares range from 834581776 to 834585935. The ISIN number for the shares issued in Demat form is INE089A01031.

Following the allotment, the total issued shares now stand at 83,45,86,935, bringing the total issued share capital to Rs. 83,45,86,935.

These shares rank pari passu with the existing shares.

Details of Equity Shares Allotment
ParticularsDetails
Number of Shares Allotted4,160
Par Value per ShareRe. 1
Exercise Price per ShareRe. 1
Date of AllotmentAugust 20, 2025
Total Issued Shares after Allotment83,45,86,935
Total Share Capital after AllotmentRs. 83,45,86,935

The total paid-up capital after this issue is 83,45,85,935 equity shares of Re.1 each, totaling Rs. 83,45,85,935 (reflecting a difference of 1,000 due to forfeited shares of Re. 1 each in September 1988 resulting from non-payment of allotment money.)

Alpha Desk
first published: Aug 20, 2025 12:06 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347